NY S03347 | 2023-2024 | General Assembly

Status

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 30 2023 - 25% progression, died in committee
Action: 2024-01-03 - REFERRED TO ALCOHOLISM AND SUBSTANCE USE DISORDERS
Pending: Senate Alcoholism and Substance Use Disorders Committee
Text: Latest bill text (Introduced) [HTML]

Summary

Requires facilities that provide treatment for substance use disorders to have at least one practitioner qualified to administer or prescribe buprenorphine to individuals in their care with substance use disorders related to opioids.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Requires facilities that provide treatment for substance use disorders to have at least one practitioner qualified to administer or prescribe buprenorphine to individuals in their care with substance use disorders related to opioids.

Sponsors


Roll Calls

2023-02-08 - Senate - Senate Alcoholism and Substance Abuse Committee Vote (Y: 7 N: 0 NV: 0 Abs: 0) [PASS]

History

DateChamberAction
2024-01-03SenateREFERRED TO ALCOHOLISM AND SUBSTANCE USE DISORDERS
2023-02-08SenateREPORTED AND COMMITTED TO FINANCE
2023-01-30SenateREFERRED TO ALCOHOLISM AND SUBSTANCE USE DISORDERS

Same As/Similar To

A01055 (Same As) 2024-01-03 - referred to ways and means

New York State Sources


Bill Comments

feedback